(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 5.1% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Sotera Health Co's revenue in 2026 is $1,216,173,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $359,286,866,905, with the lowest SHC revenue forecast at $347,301,125,515, and the highest SHC revenue forecast at $374,697,105,835. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $380,689,976,530, with the lowest SHC revenue forecast at $366,991,986,370, and the highest SHC revenue forecast at $398,097,839,025.
In 2028, SHC is forecast to generate $403,234,585,335 in revenue, with the lowest revenue forecast at $388,395,095,995 and the highest revenue forecast at $422,069,321,805.